Dallas-based MedCAD has received 510 (k) FDA clearance for its AccuStride fixation plates.
The plates are part of the company’s complete foot and ankle system, which is designed to be used for revision procedures, deformities, arthritic or diabetic conditions and trauma-related foot and ankle injuries, according to a Nov. 6 news release from MedCAD.
Components of the AccuStride system are made out of UV-curable acrylate polymers or titanium alloy materials.
The company earned FDA clearance for the system’s guides and planning system in March 2025, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
